Chafic Karam

2.6k total citations
71 papers, 910 citations indexed

About

Chafic Karam is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chafic Karam has authored 71 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Neurology, 28 papers in Molecular Biology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chafic Karam's work include Amyloidosis: Diagnosis, Treatment, Outcomes (25 papers), Peripheral Neuropathies and Disorders (14 papers) and Hereditary Neurological Disorders (11 papers). Chafic Karam is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (25 papers), Peripheral Neuropathies and Disorders (14 papers) and Hereditary Neurological Disorders (11 papers). Chafic Karam collaborates with scholars based in United States, Netherlands and Italy. Chafic Karam's co-authors include Stephen N. Scelsa, Daniel J. MacGowan, Sabrina Paganoni, Richard Bedlack, Gregory T. Carter, Nanette C. Joyce, Rabih Talhouk, Wassim El-Jouni, Elie K. Barbour and Sami Khella and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the American College of Cardiology.

In The Last Decade

Chafic Karam

66 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chafic Karam United States 18 393 336 181 95 90 71 910
Qun Wu China 19 399 1.0× 488 1.5× 49 0.3× 170 1.8× 71 0.8× 48 1.4k
Kongkiat Kulkantrakorn Thailand 19 428 1.1× 143 0.4× 32 0.2× 251 2.6× 72 0.8× 49 1.2k
Khanh vinh quốc Lương United States 17 138 0.4× 117 0.3× 35 0.2× 116 1.2× 49 0.5× 48 776
Sara Zarei United States 7 355 0.9× 161 0.5× 142 0.8× 77 0.8× 52 0.6× 19 657
Hiroshi Mihara Japan 15 147 0.4× 121 0.4× 74 0.4× 100 1.1× 54 0.6× 70 820
Qi Lin China 19 63 0.2× 248 0.7× 44 0.2× 124 1.3× 107 1.2× 45 913
Deshandra M. Raidoo South Africa 19 62 0.2× 242 0.7× 381 2.1× 161 1.7× 145 1.6× 38 1.2k
Fei Yang China 15 393 1.0× 105 0.3× 91 0.5× 97 1.0× 90 1.0× 67 689
Isabella Peixoto de Barcelos United States 10 46 0.1× 286 0.9× 24 0.1× 89 0.9× 29 0.3× 20 552

Countries citing papers authored by Chafic Karam

Since Specialization
Citations

This map shows the geographic impact of Chafic Karam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chafic Karam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chafic Karam more than expected).

Fields of papers citing papers by Chafic Karam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chafic Karam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chafic Karam. The network helps show where Chafic Karam may publish in the future.

Co-authorship network of co-authors of Chafic Karam

This figure shows the co-authorship network connecting the top 25 collaborators of Chafic Karam. A scholar is included among the top collaborators of Chafic Karam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chafic Karam. Chafic Karam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nienhuis, Hans, David Adams, Chafic Karam, et al.. (2024). Neurofilament Light Chain in Systemic Amyloidosis: A Systematic Review. Preprints.org. 2 indexed citations
3.
Nienhuis, Hans, David Adams, Chafic Karam, et al.. (2024). Neurofilament Light Chains in Systemic Amyloidosis: A Systematic Review. International Journal of Molecular Sciences. 25(7). 3770–3770. 7 indexed citations
4.
Karam, Chafic, et al.. (2024). The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement. Orphanet Journal of Rare Diseases. 19(1). 419–419. 2 indexed citations
5.
Karam, Chafic, Michelle L. Mauermann, Alejandra González‐Duarte, et al.. (2024). Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts. Muscle & Nerve. 69(3). 273–287. 7 indexed citations
6.
Yarlas, Aaron, et al.. (2023). The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy. BMC Neurology. 23(1). 108–108. 7 indexed citations
7.
8.
9.
10.
Rebello, Sabrina, José Nativi-Nicolau, Chafic Karam, et al.. (2022). FINANCIAL TOXICITY AND PATIENT-REPORTED ECONOMIC BURDEN IN PATIENTS WITH ATTR: RESULTS FROM AMYLOIDOSIS RESEARCH CONSORTIUM’S ATTR TREATMENT AFFORDABILITY PATIENT AND CAREGIVER SURVEY. Journal of the American College of Cardiology. 79(9). 301–301. 2 indexed citations
11.
Wencel, Marie, Aziz Shaibani, Namita Goyal, et al.. (2021). Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices. Neurology Genetics. 7(6). e623–e623. 5 indexed citations
12.
Yarlas, Aaron, Kristen McCausland, Duncan Brown, et al.. (2021). Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR. Neurology and Therapy. 10(2). 865–886. 8 indexed citations
13.
Ensrud, Erik, et al.. (2021). CIDP mimics: a case series. BMC Neurology. 21(1). 94–94. 3 indexed citations
14.
Chahin, Nizar, et al.. (2020). IVIG Refractory CIDP: Clinical Characteristics, Antibodies, and Response to Alternative Treatment (2504). Neurology. 94(15_supplement). 1 indexed citations
15.
Dyck, P. James B., Teresa Coelho, Márcia Waddington‐Cruz, et al.. (2020). Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis. Muscle & Nerve. 62(4). 509–515. 15 indexed citations
16.
Karam, Chafic, et al.. (2019). Bright tongue sign in patients with late-onset Pompe disease. Journal of Neurology. 266(10). 2518–2523. 15 indexed citations
17.
Statland, Jeffrey, Anthony A. Amato, Elena Bravver, et al.. (2018). Preliminary Results from a Phase 2 Study to Evaluate ACE-083, a Local Muscle Therapeutic, in Patients with Facioscapulohumeral Muscular Dystrophy (S38.001). Neurology. 90(15_supplement). 4 indexed citations
18.
19.
Karam, Chafic, et al.. (2015). Human immune globulin infusion in the management of multifocal motor neuropathy. PubMed. 6. 1–1. 4 indexed citations
20.
Talhouk, Rabih, et al.. (2007). Anti-Inflammatory Bioactivities in Plant Extracts. Journal of Medicinal Food. 10(1). 1–10. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qun Wu Breakdown of academic impact, for papers by Kongkiat Kulkantrakorn Breakdown of academic impact, for papers by Khanh vinh quốc Lương Breakdown of academic impact, for papers by Sara Zarei Breakdown of academic impact, for papers by Hiroshi Mihara Breakdown of academic impact, for papers by Qi Lin Breakdown of academic impact, for papers by Deshandra M. Raidoo Breakdown of academic impact, for papers by Fei Yang Breakdown of academic impact, for papers by Isabella Peixoto de Barcelos
Rankless by CCL
2026